6.
Darwitz B, Genito C, Thurlow L
. Triple threat: how diabetes results in worsened bacterial infections. Infect Immun. 2024; 92(9):e0050923.
PMC: 11385445.
DOI: 10.1128/iai.00509-23.
View
7.
G C B, Sahukhal G, Elasri M
. Delineating the Role of the Operon in Staphylococcal Overflow Metabolism. Front Microbiol. 2022; 13:914512.
PMC: 9204165.
DOI: 10.3389/fmicb.2022.914512.
View
8.
Genito C, Darwitz B, Reber C, Moorman N, Graves C, Monteith A
. mTOR signaling is required for phagocyte free radical production, GLUT1 expression, and control of infection. mBio. 2024; 15(6):e0086224.
PMC: 11324022.
DOI: 10.1128/mbio.00862-24.
View
9.
Smith T, Pearson M, WILCOX K, Cruz C, Lancaster M, Robinson-Dunn B
. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med. 1999; 340(7):493-501.
DOI: 10.1056/NEJM199902183400701.
View
10.
Miller L, Quan C, Shay A, Mostafaie K, Bharadwa K, Tan N
. A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clin Infect Dis. 2007; 44(4):483-92.
DOI: 10.1086/511041.
View
11.
Yi H, Huang J, Guo L, Zhang Q, Qu J, Zhou M
. Increased Antimicrobial Resistance among Sputum Pathogens from Patients with Hyperglycemia. Infect Drug Resist. 2020; 13:1723-1733.
PMC: 7295332.
DOI: 10.2147/IDR.S243732.
View
12.
Wielgoss S, Barrick J, Tenaillon O, Wiser M, Dittmar W, Cruveiller S
. Mutation rate dynamics in a bacterial population reflect tension between adaptation and genetic load. Proc Natl Acad Sci U S A. 2012; 110(1):222-7.
PMC: 3538217.
DOI: 10.1073/pnas.1219574110.
View
13.
Ogurtsova K, Guariguata L, Barengo N, Ruiz P, Sacre J, Karuranga S
. IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021. Diabetes Res Clin Pract. 2021; 183:109118.
DOI: 10.1016/j.diabres.2021.109118.
View
14.
Tan T, Shih C, Concha-Moore K, Diri M, Hu B, Marrero D
. Disparities in outcomes of patients admitted with diabetic foot infections. PLoS One. 2019; 14(2):e0211481.
PMC: 6361439.
DOI: 10.1371/journal.pone.0211481.
View
15.
Hanses F, Park S, Rich J, Lee J
. Reduced neutrophil apoptosis in diabetic mice during staphylococcal infection leads to prolonged Tnfα production and reduced neutrophil clearance. PLoS One. 2011; 6(8):e23633.
PMC: 3166063.
DOI: 10.1371/journal.pone.0023633.
View
16.
Chavez-Reyes J, Escarcega-Gonzalez C, Chavira-Suarez E, Leon-Buitimea A, Vazquez-Leon P, Morones-Ramirez J
. Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia. Front Public Health. 2021; 9:559595.
PMC: 7921169.
DOI: 10.3389/fpubh.2021.559595.
View
17.
Barreteau H, Kovac A, Boniface A, Sova M, Gobec S, Blanot D
. Cytoplasmic steps of peptidoglycan biosynthesis. FEMS Microbiol Rev. 2008; 32(2):168-207.
DOI: 10.1111/j.1574-6976.2008.00104.x.
View
18.
Keogh R, Haeberle A, Langouet-Astrie C, Kavanaugh J, Schmidt E, Moore G
. Group B adaptation promotes survival in a hyperinflammatory diabetic wound environment. Sci Adv. 2022; 8(45):eadd3221.
PMC: 9651866.
DOI: 10.1126/sciadv.add3221.
View
19.
. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022; 399(10325):629-655.
PMC: 8841637.
DOI: 10.1016/S0140-6736(21)02724-0.
View
20.
Genito C, Darwitz B, Greenwald M, Wolfgang M, Thurlow L
. Hyperglycemia potentiates increased virulence and resistance to growth inhibition by . Microbiol Spectr. 2023; 11(6):e0229923.
PMC: 10715105.
DOI: 10.1128/spectrum.02299-23.
View